In a meta‐analysis performed on eight studies on the association between AXIN2 rs2240308 polymorphism and overall cancer risk (2015), Gong et al showed decreased cancer risk in the homozygous, heterozygous, dominant, and allelic (T vs. C) models.28 This evidence concerns the gene AXIN2 and cancer.